Robin Park
Psychiatry · Creve Coeur, MONPI 1407871213
Payments from drug & device makers
Across 357 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$2K
- Neos Therapeutics, LP$454
- Neurocrine Biosciences, Inc.$394
- AbbVie$318
- Otsuka America Pharmaceutical, Inc.$267
- Tris Pharma Inc$265
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,71599%
- Education$761%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 118 | $1,783 |
| Neos Therapeutics, LP | 26 | $454 |
| Neurocrine Biosciences, Inc. | 19 | $394 |
| AbbVie(2 entities) | 24 | $318 |
| Otsuka America Pharmaceutical, Inc. | 16 | $267 |
| Tris Pharma Inc | 15 | $265 |
| Supernus Pharmaceuticals, Inc. | 14 | $252 |
| Ironshore Pharmaceuticals Inc. | 16 | $248 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $221 |
| Teva Pharmaceuticals USA, Inc. | 8 | $216 |
| Johnson & Johnson | 11 | $194 |
| Rhodes Pharmaceuticals L.p. | 21 | $181 |
| Vanda Pharmaceuticals Inc. | 9 | $170 |
| Lundbeck LLC | 5 | $114 |
| Avanir Pharmaceuticals, Inc. | 6 | $113 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $99 |
| Alkermes, Inc. | 4 | $78 |
| Shire North American Group Inc | 5 | $74 |
| Adlon Therapeutics L.p. | 4 | $67 |
| Vertical Pharmaceuticals, LLC | 4 | $61 |
| Noven Therapeutics, LLC | 3 | $56 |
| Idorsia Pharmaceuticals US Inc | 3 | $52 |
| Arbor Pharmaceuticals, Inc. | 2 | $35 |
| Novo Nordisk | 1 | $22 |
| Bausch Health US, LLC | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $11 |
How this compares
$5,790 in reported general payments places this provider in the 85th percentile of 680 psychiatry providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 24 | $12,079 |
| Chlorpromazine Hcl | 24 | $6,396 |
| Aripiprazole | 62 | $6,358 |
| Methylphenidate ErMethylphenidate Hcl | 24 | $3,712 |
| Lisdexamfetamine Dimesylate | 12 | $2,127 |
| Lurasidone Hcl | 19 | $1,873 |
| Lamotrigine | 69 | $1,689 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 47 | $1,471 |
| Olanzapine | 85 | $1,345 |
| Divalproex Sodium | 13 | $1,229 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 27 | $1,095 |
| Bupropion XlBupropion Hcl | 44 | $1,016 |
| Doxepin Hcl | 20 | $1,004 |
| Naltrexone Hcl | 12 | $965 |
| Quetiapine Fumarate | 63 | $959 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $221 | $12,07924 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 680 psychiatry providers in Missouri.
Other psychiatry in Creve Coeur
- Arturo TacaCreve Coeur$258K
- Gregory MattingleySaint Charles$8.2M
- Junaid SyedSaint Louis$8M
- Eric CarbonellFestus$5.4M
- Ricky MofsenSaint Louis$4.9M
- Charles ConwaySaint Louis$3.8M
- Mohd MalikSaint Louis$2.8M
- Franco SicuroOlivette$2.3M
- Howard IlivickySaint Charles$2.1M
- Vadim BaramSaint Louis$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.